How to buy Oracle (ORCL) stock from India

Yes, an Indian resident can buy Oracle — legally, in US dollars, under the RBI's Liberalised Remittance Scheme (LRS). The buying is the easy 10%. The 90% that decides your outcome is dividend withholding, capital-gains tax, estate-tax exposure, and position sizing in a name that has been re-rated on the AI-cloud thesis. This is the short version.

The 30-second version

• Legal and simple. Buy ORCL via IBKR, Rovia, INDmoney, or Vested. Whole shares or a fractional rupee amount.
• Dividend + capital gains. Oracle pays roughly a 1% dividend (a $0.50 quarterly payout, regularly grown), so the 25% US dividend withholding does matter — and is creditable in India via Form 67.
• India tax on gains: more than 24 months → 12.5% LTCG (no indexation); sooner → your slab rate. Section 112, not the friendlier 112A that Indian shares get.
• The trap most miss: directly-held ORCL is a US-situs asset — above $60,000, your estate faces up to 40% US estate tax, with no India-US treaty relief.
• If your thesis is "US tech," VOO and VTI already hold ORCL — at a smaller weight than the hyperscaler trio of Microsoft, Amazon, and Google.

Quick facts

Can an Indian resident buy it?	Yes — fully legal under the LRS
Ticker / exchange	ORCL / NYSE
How	IBKR, Rovia, INDmoney, or Vested
Minimum	A fraction of one share
Dividend	≈1% yield; $0.50 quarterly, regularly raised
US dividend WHT	25% at source; creditable via Form 67
India tax on gains	12.5% LTCG after 24 months; else slab (Section 112)
Estate-tax risk	US-situs above $60k → up to 40%, no treaty relief
Annual compliance	Schedule FA disclosure, every year you hold

How to buy it — 3 steps

1. Open an account and finish KYC. Use IBKR for the widest access and best execution, Rovia for a combined RSU + LRS experience, or INDmoney / Vested for a simple India-funded flow. Not sure which to pick? Compare Vested vs INDmoney vs Interactive Brokers. New to this? Start with how to invest in US stocks from India.
2. Fund it via the LRS. Remit from your Indian bank under the LRS (cap: $250,000 per financial year). 20% TCS above ₹10 lakh in a year is a creditable prepayment, not a cost. See LRS explained and the LRS and TCS calculator. For the full compliance picture, see the LRS + TCS + Schedule FA trifecta.
3. Place the order. ORCL trades on the NYSE in regular US market hours. A whole share is affordable on most platforms, or buy a fractional rupee amount.

The tax that actually matters

Oracle is one of the rare US tech names that pays a real (if modest) dividend, so the tax story has two layers.

Dividends. The US withholds 25% at source. The gross dividend is then taxable in India at your slab rate, but you can claim a foreign tax credit for the 25% by filing Form 67 before your ITR. Walkthrough: dividend withholding and Form 67 and the Form 67 / FTC calculator.

Capital gains. Taxed under Section 112 (foreign shares don't get the Section 112A treatment Indian-listed equity enjoys):

Holding period	Treatment	Rate
24 months or less	Short-term	Your slab rate (up to ≈30%+)
More than 24 months	Long-term	12.5%, no indexation

Worked example. Buy 20 shares at $190 when USD/INR is 93 → cost ₹3,26,800. Sell 30 months later at $240 when USD/INR is 95 → proceeds ₹4,22,400. Taxable gain ₹95,600; LTCG at 12.5% = ₹11,950. The gain is computed in rupees, so the currency move is baked in. Model your own with the US capital-gains calculator; full rules in how US stocks are taxed in India. The India-US tax treaty (DTAA) guide covers dividend withholding relief and treaty benefits.

The $60,000 estate-tax trap

Directly-held ORCL is a US-situs asset. If the holder dies with more than $60,000 of US-situs assets, the estate faces US estate tax up to 40% — and the India-US treaty does not cover estate tax, so there's no credit or relief. It's the most under-appreciated risk in direct US holding, and the fix (pooled or fund structures instead of direct shares) has to be a deliberate choice made before the position gets large. Full detail: the $60,000 estate-tax trap.

Buy the stock, or get Oracle through an ETF?

If you want…	Best route
A concentrated bet that OCI keeps outgrowing the hyperscalers	ORCL directly
"US tech / AI-cloud will keep winning" exposure	VOO or VTI — ORCL is in there, plus hundreds of others
The least single-stock risk	A broad ETF

ORCL is in VOO and VTI, at a smaller weight than the hyperscaler trio of Microsoft, Amazon, and Google — so an S&P 500 fund gives you Oracle plus the rest of the AI-infrastructure stack in one wrapper. Compare in direct stocks vs US ETFs and best US ETFs for Indian investors; the broader case is in US ETFs for Indians.

The business in one screen

What it is: Oracle is the world's largest enterprise database vendor and, more recently, the fastest-growing of the major cloud providers. OCI has scaled from fourth-place curiosity to a serious AI-training platform, anchored by huge multi-year contracts and a remaining-performance-obligations backlog that has crossed half a trillion dollars.

Bull case	Bear case
OCI growing fastest of the big clouds off a smaller base	Massive AI-capex straining the balance sheet
Huge AI-infra contracts (OpenAI/Stargate, TikTok, xAI, Meta, Nvidia)	Valuation re-rated dramatically — priced for perfection
Multi-cloud links with Azure, AWS, GCP open enterprise migration	Execution risk on converting a backlog this size
Database franchise durable and cash-generative	Legacy database growth slow; key-customer concentration

Exact valuation is in the live widget above — a genuinely transformed business priced for that transformation to keep delivering.

Our take

Verdict: BUY — Oracle Cloud Infrastructure has emerged as the genuine third hyperscaler for AI workloads, with a multi-year backlog of GPU-cluster reservations from OpenAI, Microsoft, and other AI labs that competitors have not been able to fill at Oracle's speed and price. The database-to-cloud transition is now generating durable revenue acceleration.

• OCI is winning AI infrastructure contracts the big three cannot fulfill. GPU cluster deployments at Oracle's customised data centres have attracted OpenAI (training Grok and GPT models), major financial institutions, and government agencies. The backlog visible in remaining performance obligations has been growing at 50%+ YoY.
• The database moat is funding the cloud expansion. Oracle's legacy database business generates high-margin cash flows that fund capex at a scale AWS, Azure, and GCP cannot easily undercut on pure price. Autonomous Database and Exadata Cloud Service are the migration vehicles that keep customers inside the Oracle ecosystem.
• Ellison's AI positioning has been prescient. Larry Ellison's early investments in GPU infrastructure (before the broader AI buildout was visible to the market) have given Oracle a capacity lead in sovereign cloud and specialised AI training deployments. That positioning is now converting to contracted revenue.
• Still carries execution risk. Capex is running at hyperscaler scale on a smaller revenue base. Backlog conversion timelines can slip; customer concentration is real. Size as a growth satellite rather than a defensive holding.

Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.

Risks to size for

• Valuation re-rating: priced on the AI thesis; any wobble in OCI growth or capex discipline can compress the multiple fast.
• Customer concentration: a small set of frontier-AI buyers underpin a very large slice of the backlog.
• Currency: your return is in USD but you spend rupees — see the rupee-dollar effect.

Two things people forget

• Schedule FA: disclose ORCL — and its dividends — in Schedule FA of your ITR every year you hold it, even if bought and sold within the year, even at a loss. Non-disclosure carries Black Money Act penalties. Use the Schedule FA helper. See the Schedule FA disclosure guide for full details.
• Claim the dividend credit: the 25% US withholding is creditable, not lost — but only if you file Form 67 before your ITR. Skip it and you effectively pay tax twice on the same dividend.

Bottom line

Buying ORCL from India is easy and legal. What needs thought isn't the buying — it's that Oracle is a Section-112 capital-gains play (12.5% after 24 months), a dividend payer with 25% US withholding to reclaim via Form 67, a US-situs asset with a $60k estate-tax trap, and a name priced for its AI-cloud second act to keep compounding. If your real thesis is "US tech and AI infrastructure," a broad ETF gives you Oracle plus everyone competing for the same workloads. For accounts and options, start at the US investing hub.

Related stocks and ETFs to consider

Indian investors researching Oracle often also look at:

• Microsoft from India — cloud, AI (Azure + Copilot), and enterprise software
• Alphabet (Google) from India — search, cloud (GCP), and AI
• Meta from India — social media and AI advertising
• Best US ETFs for Indian investors — a diversified alternative

---

This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.